Biomea Fusion (BMEA) is the lead sponsor of 4 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 2 Phase 1[2].
BMEA is tracked by BiotechSigns with a current catalyst score of 39/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Biomea Fusion (BMEA) is the lead sponsor of 4 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 2 Phase 1[2].